1. Home
  2. RVYL vs ASBP Comparison

RVYL vs ASBP Comparison

Compare RVYL & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RVYL

Ryvyl Inc.

HOLD

Current Price

$7.81

Market Cap

8.5M

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$5.93

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
ASBP
Founded
2007
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
6.8M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
RVYL
ASBP
Price
$7.81
$5.93
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.1K
263.1K
Earning Date
04-15-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,131,000.00
N/A
Revenue This Year
$770.54
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.05
52 Week High
$8.55
$7.05

Technical Indicators

Market Signals
Indicator
RVYL
ASBP
Relative Strength Index (RSI) 67.46 58.88
Support Level $5.00 $0.21
Resistance Level $8.55 $7.05
Average True Range (ATR) 0.65 0.94
MACD 0.11 -0.15
Stochastic Oscillator 96.06 66.32

Price Performance

Historical Comparison
RVYL
ASBP

About RVYL Ryvyl Inc.

Ryvyl Inc is a financial technology company that provides payment acceptance and disbursement solutions, mainly enabling merchants to process credit card transactions through BIN sponsorship arrangements with acquiring banks and payment processors, where it operates as an intermediary performing functions such as merchant underwriting, onboarding, risk monitoring, and customer support. The company also offers its internally developed NEMS Core platform, which facilitates automated inbound and outbound disbursements through a modular workflow system.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Share on Social Networks: